Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akira Takenaka is active.

Publication


Featured researches published by Akira Takenaka.


Journal of Japanese Society for Dialysis Therapy | 1993

Study of recombinant human erthropoietin administration for anemia in hemodialysis patients. Clinical study of dose determination.

Tadayuki Miyamoto; Akira Numata; Makoto Yuasa; Yasuo Kawanishi; Masato Tamura; Atsuko Furukawa; Susumu Kagawa; Takehiko Yokota; Yoichi Aga; Kiyoshi Tatara; Hiroshi Yamamoto; Kouji Hiraishi; Akihiko Fujisawa; Akira Kawano; Masaki Otani; Toshiyuki Yamashita; Yoshihide Murakami; Shouichirou Nakamura; Kozo Kitada; Keiji Kojima; Naotami Terao; Kenji Yuasa; Akira Takenaka; Hirohumi Hashimoto; Yoshio Inoue; Mikio Nakajima; Fumio Yoneda; Haruhiro Tsujimura; Masuhiro Noda; Nobuta Fujisaki

目的: 腎性貧血に対するリコンビナント・ヒト・エリスロポエチン (r-HuEPO) の至適投与量を明らかにするため多施設共同試験を実施した. 対象と方法: 慢性腎不全血液透析患者でHt値25%以下の症例273例を対象とした. 初期投与を3群 (1,500IU×3/W, 1,500IU×2/W, 3,000×2/W) に分類し, Ht値が27-33%に達した時点より維持投与に移行し, Ht値を30%前後に維持するように投与量を変更もしくは休薬した. 結果: 初期投与では投与後4週後のHt値は3群とも有意な上昇を示し, 3群間では3,000×2/Wが有意に高値であり, その効果は用量依存性であった. 12週目では3群間に差がなく, 貧血改善を緩徐に行うためには1,500IU×2/Wで十分であった. 維持投与量は, 低用量に移行し, 4,500IU/W以下が約80%を占めた. しかしながらHt値30%を維持するためには25%の症例で6,000IU/Wの投与が必要であった. 副作用は34例 (12.5%) に認められ, 主要な副作用は血圧上昇で, 投与量が増えるに従い, その発生頻度が増加した. 6,000IU/W投与する場合, 血圧の上昇を懸念する必要があると思われた.


Journal of Japanese Society for Dialysis Therapy | 1989

Pheochromocytoma in a patient on chronic hemodialysis: A case Report

Tadayuki Miyamoto; Fumito Komatsu; Hirofumi Hasimoto; Akira Takenaka; Kazunori Kuwabara; Naotami Terao; Takao Saito


Nihon Toseki Igakkai Zasshi | 1996

Tumoral calcinosis at the posterior cervical region successfully treated by surgical resection in a hemodialysis patient: A case report

Tomoharu Fukumori; Kenji Yuasa; Akihiro Yamamoto; Hiroshi Nishikawa; Fumito Komatsu; Shigeru Matsumoto; Akira Takenaka; Naotami Terao


Nihon Toseki Igakkai Zasshi | 1995

Assessment of the efficacy of sodium ferrous citrate in hemodialysis patients with an iron saturation index of less than 16

Kenji Yuasa; Tomoharu Fukumori; Hiroshi Nishikawa; Shoichi Yamamoto; Akihiro Yamamoto; Akira Takenaka; Naotami Terao


Japanese journal of endourology and ESWL | 1995

Extracorporeal Shock Wave Lithotripsy for the Treatment of Staghorn Calculi in 72 Patients

Tomoharu Fukumori; Hiroshi Nishikawa; Akihiro Yamamoto; Akira Takenaka; Naotami Terao


Nihon Toseki Igakkai Zasshi | 1994

Clinical study of synovial fluid in dialysis amyloid osteoarthropathy patients

Hirofumi Hashimoto; Naotami Terao; Masahito Yamanaka; Shinichi Kataoka; Akira Takenaka; Kenji Yuasa; Masanobu Tanimura; Mutsuo Furihata; Yuji Ohtsuki; Kinya Yokota; Takehiko Yokota; Susumu Kagawa


Journal of Japanese Society for Dialysis Therapy | 1992

Long-term administration of Desferrioxamine in patients with Al and Fe deposition in bone.

Naotami Terao; Hirofumi Hashimoto; Kenji Yuasa; Akira Takenaka; Yasukazu Sen; Masahito Yamanaka; Yuji Ohtsuki


Journal of Japanese Society for Dialysis Therapy | 1991

Clinical significance of .ALPHA.-human atrial natriuretic peptide in patients on hemodialysis.

Kenji Yuasa; Masato Yamanaka; Yasukazu Sen; Hirofumi Hashimoto; Akira Takenaka; Naotami Terao; Hironori Maeda


Journal of Japanese Society for Dialysis Therapy | 1989

Bone tissue on chronic renal failure patients before introduction of hemodialysis

Hirofumi Hashimoto; Fumito Komatsu; Tadayuki Miyamoto; Akira Takenaka; Naotami Terao; Kazunori Kuwabara; Yuji Ohtsuki


Journal of Japanese Society for Dialysis Therapy | 1989

Morphological classification of the kidney in patients undergoing chronic hemodialysis

Akira Takenaka; Fumito Komatu; Tadayuki Miyamoto; Hirofumi Hashimoto; Naotami Terao; Kazunori Kuwabara

Collaboration


Dive into the Akira Takenaka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akio Imagawa

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Akira Kawano

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Akira Numata

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fumio Yoneda

University of Tokushima

View shared research outputs
Researchain Logo
Decentralizing Knowledge